Azathioprine is a commonly prescribed therapy for connective tissue disease-associated interstitial generic for imuran fibrosis disease Generic for imuran fibrosis. Combination therapy that included azathioprine was recently shown to increase the risk of death and hospitalization in patients with idiopathic generic for imuran fibrosis fibrosis.
A retrospective cohort analysis was performed to determine the combined incidence rate of death, transplant and respiratory hospitalization associated with azathioprine exposure.
Fibrosis rates were compared with generic for imuran fibrosis incidence rate ratio IRR generated by negative binomial regression. Longitudinal pulmonary function response was then assessed using mixed effects linear regression models.
Fifty-four patients were treated with azathioprine and forty-three with mycophenolate.
The combined incidence rate of adverse outcomes generic for 0. Both groups demonstrated fibrosis function stability over time, with the azathioprine generic imuran fibrosis imuran generic for imuran fibrosis a marginal improvement.
A significant minority of patients could not tolerate azathioprine generic for imuran fibrosis to non-respiratory side effects. Of those who did check this out azathioprine, a similar incidence of adverse outcomes was observed as those treated with mycophenolate.
Both therapies were associated with stability in pulmonary function.
2018 ©